Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry

Arbuckle, M.R. et al. Autoantibodies are present years before the clinical onset of systemic lupus erythematosus. N. Engl. J. Med. 349, 1526–1533 (2003).

Dale, J.B. & Beachey, E.H. Epitopes of streptococcal M proteins shared with cardiac myosin. J. Exp. Med. 162, 583–591 (1985).

Olson, J.K., Croxford, J.L., Calenoff, M.A., Dal Canto, M.C. & Miller, S.D. A virus-induced molecular mimicry model of multiple sclerosis. J. Clin. Invest. 108, 311–318 (2001).

Kirvan, C.A., Swedo, S.E., Heuser, J.S. & Cunningham, M.W. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat. Med. 9, 914–920 (2003).

Levin, M.C. et al. Autoimmunity due to molecular mimicry as a cause of neurological disease. Nat. Med. 8, 509–513 (2002).

James, J.A. et al. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J. Clin. Invest. 100, 3019–3026 (1997).

James, J.A. et al. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum. 44, 1122–1146 (2001).

Ascherio, A. et al. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA 286, 3083–3038 (2001).

McClain, M.T., Harley, J.B. & James, J.A. The role of Epstein-Barr virus in systemic lupus erythematosus. Front. Biosci. 6, e137–147 (2001).

Vaughan, J.H., Nguyen, M.D., Valbracht, J.R., Patrick, K. & Rhodes, G.H. Epstein-Barr virus-induced autoimmune responses. II. Immunoglobulin G autoantibodies to mimicking and nonmimicking epitopes. Presence in autoimmune disease. J. Clin. Invest. 95, 1316–1327 (1995).

McClain, M.T., Rapp, E.C., Harley, J.B. & James, J.A. Infectious mononucleosis patients temporarily recognize a unique, cross-reactive epitope of Epstein-Barr virus nuclear antigen-1. J. Med. Virol. 70, 253–257 (2003).

Sabbatini, A., Bombardieri, S. & Migliorini, P. Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein-Barr virus-encoded nuclear antigen EBNA I. Eur. J. Immunol. 23, 1146–1152 (1993).

James, J.A. & Harley, J.B. Linear epitope mapping of an Sm B/B′ polypeptide. J. Immunol. 148, 2074–2079 (1992).

James, J.A., Scofield, R.H. & Harley, J.B. Lupus humoral autoimmunity after short peptide immunization. Ann. NY Acad. Sci. 5, 124–127 (1997).

Riemekasten, G. et al. A novel epitope on the C-terminus of Sm D1 is recognized by the majority of sera from patients with systemic lupus erythematosus. J. Clin. Invest. 102, 754–763 (1998).

Arbuckle, M.R., Reichlin, M., Harley, J.B. & James, J.A. Shared early autoantibody recognition events in the development of anti-Sm B/B′ in human lupus. Scand. J. Immunol. 50, 447–455 (1999).

Huang, S.C., Scofield, R.H. & Harley, J.B. Human anti-Ro autoantibodies bind multiple conformational epitopes of 60 kDa Ro autoantigen. J. Clin. Immunol. 156, 4059–4066 (1997).

Scofield, A.N., Kurien, B.T., Gordon, T.P. & Scofield, R.H. Can B cell epitopes of 60 kDa Ro distinguish systemic lupus erythematosus from Sjögren's syndrome? Lupus 10, 547–553 (2001).

Routsias, J.G. et al. Structural, molecular and immunological properties of linear B-cell epitopes of Ro 60 KD autoantigen. Scand. J. Immunol. 47, 280–287 (1998).

McClain, M.T. et al. Structural availability influences the capacity of autoantigenic epitopes to induce a widespread lupus-like autoimmune response. Proc. Natl. Acad. Sci. USA 101, 3551–3556 (2004).

McClain, M.T., Ramsland, P.A., Kaufman, K.M. & James, J.A. Anti-Sm autoantibodies in systemic lupus target highly basic surface structures of complexed spliceosomal autoantigens. J. Immunol. 168, 2054–2062 (2002).

McClain, M.T., Scofield, R.H., Kurien, B.T., Gross, T.F. & James, J.A. Selective small antigenic structures are capable of inducing widespread autoimmunity which closely mimics the humoral fine specificity of human SLE. Scand. J. Immunol. 56, 399–407 (2002).

Deshmukh, U.S. et al. Ro60 peptides induce antibodies to similar epitopes shared among lupus–related autoantigens. J. Immunol. 164, 6655–6661 (2000).

Deshmukh, U.S. et al. Immune responses to Ro60 and its peptides in mice. I. The nature of the immunogen and endogenous autoantigen determine the specificities of the induced autoantibodies. J. Exp. Med. 189, 531–540 (1999).

Thompson, M.P. & Kurzrock, R. Epstein-Barr virus and cancer. Clin. Cancer Res. 10, 803–821 (2004).

Harley, J.B. & James, J.A. Is there a role for Epstein-Barr virus in Lupus? The Immunologist 6, 79–83 (1998).

Kong, P.L. et al. Intrinsic T cell defects in systemic autoimmunity. Ann. NY Acad. Sci. 987, 60–67 (2003).

Goodnow, C.C. Balancing immunity and tolerance: deleting and tuning lymphorepertoires. Proc. Natl. Acad. Sci. USA 93, 2264–2271 (1996).

Kang, I. et al. Defective control of latent Epstein–Barr virus infection in systemic lupus erythematosus. J. Immunol. 172, 1287–1294 (2004).

Hochberg, M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40, 1725 (1998).